» Articles » PMID: 14581252

Restless Legs Syndrome Symptoms in Primary Care: a Prevalence Study

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2003 Oct 29
PMID 14581252
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There are relatively few studies on the prevalence of restless legs syndrome (RLS) in the general population, even fewer that used diagnostic questions covering all 4 essential diagnostic criteria defining the RLS symptom complex, and none that have reported on the 2 RLS phenotypes for patients seen by family physicians.

Methods: To determine the prevalence of the symptom complex, diagnostic for RLS in a primary care patient population, a prospective population-based single-center study was performed. Every adult patient presenting for care in a small rural primary care practice with mostly white patients was surveyed for a 1-year period using a validated RLS diagnostic questionnaire.

Results: A total of 2099 patients completed the questionnaire. Analysis revealed that 24.0% of these patients were positive for all 4 of the essential symptoms used to make the diagnosis of RLS and 15.3% reported these symptoms at least weekly. In addition, the RLS symptom complex was reported significantly more often by women than men and, as a whole, patients reporting the RLS symptoms were significantly older than patients without symptoms. The prevalence of symptoms increased with age until about 60 years and then showed a steady decrease thereafter. Further, early-onset RLS was significantly more common in women than men.

Conclusions: A high prevalence of RLS symptoms was observed in this primary care population. This finding supports the need for heightened awareness in both the medical community and general population regarding this disorder, which can often be effectively treated within the primary care practice.

Citing Articles

Efficacy and safety of intravenous ferric carboxymaltose in the treatment of Restless Legs Syndrome: a systematic review and meta-analysis.

Khan A, Kumar H, Rai K, Saeed A, Ishtiaq J, Alam M Front Neurol. 2025; 15():1503342.

PMID: 39839869 PMC: 11746117. DOI: 10.3389/fneur.2024.1503342.


Prevalence of Restless Leg Syndrome, Associated Variables and Impact on Sleep Quality in a Cohort of Patients with Neuropsychiatric Disorders.

Goel R, Satodiya V, Kosambiya R, Vala A Niger Med J. 2024; 65(5):705-715.

PMID: 39633705 PMC: 11612333. DOI: 10.60787/nmj-v65i3.428.


[Differential diagnosis of insomnia from other comorbid primary sleep disorders].

Ferre-Maso A, Rodriguez-Ulecia I, Garcia-Gurtubay I Aten Primaria. 2020; 52(5):345-354.

PMID: 32143969 PMC: 7231894. DOI: 10.1016/j.aprim.2019.11.011.


Improvement of Subthalamic Nucleus Deep Brain Stimulation in Sleeping Symptoms in Parkinson's Disease: A Meta-Analysis.

Zhang X, Xie A Parkinsons Dis. 2019; 2019:6280896.

PMID: 31687125 PMC: 6800928. DOI: 10.1155/2019/6280896.


Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.

Hankin C, Lee D, Garcia-Borreguero D, Wang Z J Clin Sleep Med. 2019; 15(9):1225-1232.

PMID: 31538593 PMC: 6760417. DOI: 10.5664/jcsm.7908.